Bartfeld H, Dham C, Donnenfeld H, Jashnani L, Carp R, Kascsak R, Vilcek J, Rapport M, Wallenstein S
Clin Exp Immunol. 1982 Apr;48(1):137-46.
The 'immunological profile' of amyotrophic lateral sclerosis (ALS) patients was established from standard tests for B- and T-cell function. This showed no significant difference from age and sex-matched other neurological (CNS) disease controls and normal subjects. Immune complex (IC) levels in ALS serum differed significantly from normal controls but not from CNS controls. There was no relation between the various indices of immune activity of IC levels and the clinical disability of the ALS patient or progression of the disease. Distribution of complement-fixing antibodies to poliovirus was similar to sera of ALS and control groups. The in vitro cell-mediated immune responses to poliovirus, however, were significantly greater in ALS patients than in CNS controls and were inversely related to the ALS disability score. Poliovirus has not been demonstrated in the CNS or extra-CNS tissues of ALS patients by conventional means but, if latent or defective poliovirus or related virus were present, this could account for sensitization and a possible autoimmune mechanism. ALS patients exhibited in vitro cellular immunity to ALS and normal CNS subfractions. These responses were not related to the ALS disability score or progression of the disease and probably represent epiphenomena.
肌萎缩侧索硬化症(ALS)患者的“免疫特征”是通过B细胞和T细胞功能的标准测试确定的。结果显示,与年龄和性别匹配的其他神经(中枢神经系统)疾病对照组及正常受试者相比,并无显著差异。ALS患者血清中的免疫复合物(IC)水平与正常对照组有显著差异,但与中枢神经系统疾病对照组无差异。IC水平的各种免疫活性指标与ALS患者的临床残疾程度或疾病进展之间没有关联。针对脊髓灰质炎病毒的补体结合抗体分布与ALS组和对照组的血清相似。然而,ALS患者对脊髓灰质炎病毒的体外细胞介导免疫反应明显强于中枢神经系统疾病对照组,且与ALS残疾评分呈负相关。通过传统方法在ALS患者的中枢神经系统或中枢神经系统外组织中未检测到脊髓灰质炎病毒,但如果存在潜伏或缺陷的脊髓灰质炎病毒或相关病毒,这可能解释了致敏现象及一种可能的自身免疫机制。ALS患者对ALS和正常中枢神经系统亚组分表现出体外细胞免疫。这些反应与ALS残疾评分或疾病进展无关,可能仅为附带现象。